Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

ग्रंथसूची विवरण
मुख्य लेखकों:	Shrimanker, R, Pavord, I, Price, R, Bradford, E, Keene, O, Yancey, S
स्वरूप:	Conference item
प्रकाशित:	American Thoracic Society 2018

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
द्वारा: Shrimanker, R, और अन्य
प्रकाशित: (2019)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
द्वारा: Gunsoy, N, और अन्य
प्रकाशित: (2017)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
द्वारा: Steven W. Yancey, और अन्य
प्रकाशित: (2019-09-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
द्वारा: Howell, I, और अन्य
प्रकाशित: (2024)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
द्वारा: Bel, E, और अन्य
प्रकाशित: (2014)

Mepolizumab treatment in patients with severe eosinophilic asthma.
द्वारा: Ortega, H, और अन्य
प्रकाशित: (2014)

Glucocorticoids and mepolizumab in eosinophilic asthma.
द्वारा: Bel, E, और अन्य
प्रकाशित: (2014)

Mepolizumab in refractory eosinophilic asthma.
द्वारा: Pavord, I, और अन्य
प्रकाशित: (2010)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
द्वारा: Imran Howell, और अन्य
प्रकाशित: (2024-07-01)

Mepolizumab for eosinophilic COPD
द्वारा: Sciurba, F, और अन्य
प्रकाशित: (2018)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
द्वारा: Price, D, और अन्य
प्रकाशित: (2019)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
द्वारा: Yancey, S, और अन्य
प्रकाशित: (2016)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
द्वारा: Jiang-Hua Li, और अन्य
प्रकाशित: (2021-08-01)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
द्वारा: David B. Price, और अन्य
प्रकाशित: (2019-08-01)

Mepolizumab, quality of life, and severe eosinophilic asthma.
द्वारा: Pavord, I
प्रकाशित: (2017)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
द्वारा: Ortega, H, और अन्य
प्रकाशित: (2016)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
द्वारा: Shrimanker, R, और अन्य
प्रकाशित: (2017)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
द्वारा: Haldar, P, और अन्य
प्रकाशित: (2009)

Biomarkers for severe eosinophilic asthma.
द्वारा: Yancey, S, और अन्य
प्रकाशित: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
द्वारा: Moran, AM, और अन्य
प्रकाशित: (2020)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
द्वारा: Ian D. Pavord, और अन्य
प्रकाशित: (2022-05-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
द्वारा: Shrimanker, R, और अन्य
प्रकाशित: (2017)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
द्वारा: Arian Ghassemian, और अन्य
प्रकाशित: (2021-01-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
द्वारा: Shrimanker, R, और अन्य
प्रकाशित: (2017)

Mepolizumab for eosinophilic chronic obstructive pulmonary disease
द्वारा: Pavord, I, और अन्य
प्रकाशित: (2017)

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
द्वारा: Jie Gao, और अन्य
प्रकाशित: (2018-05-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
द्वारा: Terufumi Shimoda, और अन्य
प्रकाशित: (2017-07-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
द्वारा: Connolly, CM, और अन्य
प्रकाशित: (2017)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
द्वारा: Pavord, I, और अन्य
प्रकाशित: (2012)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
द्वारा: Prazma CM, और अन्य
प्रकाशित: (2021-06-01)

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma
द्वारा: Gao J, और अन्य
प्रकाशित: (2018-04-01)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
द्वारा: Menzella F, और अन्य
प्रकाशित: (2016-06-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
द्वारा: Pavord, I, और अन्य
प्रकाशित: (2017)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
द्वारा: Charlene M. Prazma, और अन्य
प्रकाशित: (2019-05-01)

Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
द्वारा: Chio Sakai, और अन्य
प्रकाशित: (2024-07-01)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
द्वारा: Berry, M, और अन्य
प्रकाशित: (2005)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
द्वारा: Wechsler, M, और अन्य
प्रकाशित: (2017)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
द्वारा: Buendía, JA, और अन्य
प्रकाशित: (2022)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
द्वारा: Jefferson Antonio Buendía, और अन्य
प्रकाशित: (2022-06-01)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
द्वारा: Yuki Hoshino, और अन्य
प्रकाशित: (2022-04-01)

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

समान संसाधन

समान संसाधन